RE:RE:RE:RE:RE:The IPF and Chronic Cough study is now on the back burner. It can't get any worse because they don't know when they will achieve full enrollment. The timeline is already costing us big-time while another bs pp is on the horizon. If he cant land some government handout money or a partnership deal asap then I'm of the belief the business model and/or trial designs are flawed. They are simply too small to ever get to statistical significance and they knew it going in with the covid study. Now it's a backtrack as if covid was never pushed to the front of the pipeline. BB